Charwood Energy: independent expert deems the €4.10 offer fair ahead of delisting
The price of €4.10 per share offered by Biomasse Vision 2030, a company formed by the majority shareholders of Charwood Energy, was deemed fair by the independent expert Crowe HAF in the draft response document filed with the AMF on 16 November 2026. The offer will be followed by a squeeze-out at the same price.
A 16.75% premium over the last share price before the announcement
The simplified tender offer covers a maximum of 385,390 shares, representing 7.38% of the share capital and 7.45% of the theoretical voting rights, excluding the 45,494 treasury shares. It will remain open for ten trading days, and the project remains subject to review by the AMF.
The price represents a premium of 16.75% over the last share price before the announcement of 9 October 2026. The premiums reach 21.60%, 20.55%, 10.49% and 16.75% over the volume-weighted average share prices for one, three, six and twelve months.
Shares not tendered will be transferred to the initiator in exchange for compensation of €4.10 net of fees, which will result in the delisting of the security from Euronext Growth Paris. Biomasse Vision 2030 already holds 91.75% of the share capital and 91.68% of the theoretical voting rights.
This position results from the contribution in kind, on 9 October 2026, of 4,680,419 shares by the majority shareholders, at a price of €2.75 per share, and from the purchase on the same day of 110,119 shares from the company 1M86 at the offer price.
The free float represents approximately 7.4% of the share capital, with liquidity described as very low in the document.
The expert puts the premium at 62% over the sum-of-the-parts valuation
Crowe HAF retained a value of €2.53 per share using the sum-of-the-parts method, corresponding to a premium of 62.0% for the offer price. The volume-weighted average share prices over 20 and 60 days stand at €3.38 and €3.40, representing premiums of 21.5% and 20.6%.
Compared with the transactions of 9 October, the premium reaches 49.1% over the reference of the contribution in kind and is nil over the reference of the block sale. Written observations from shareholders, notably concerning the insufficiency of the price, were sent to the expert, who addresses them in the report.
Meeting on 13 November 2026, the board of directors unanimously issued a favorable opinion and recommended that shareholders tender their shares. Directors in a situation of conflict of interest deferred to the position of the ad hoc committee, chaired by Steve Levy and composed of two independent members out of three.
Adrien Haller, Julie Bouvier and Franck Mainard no longer directly hold any shares, their shares having been contributed to the initiator, and the three other directors hold none. The initiator stated that it intends to pursue the strategic direction with the current management team, the delisting being expected to reduce operating costs.